DEEPAKNTRNSEDeepak Nitrite Limited· Chemicals - OrganicMediumNeutral
Announced Thu, 26 Mar · 19:01 IST

Deepak Nitrite Limited has informed the Exchange about General Updates

Strategic Transactions View source PDF

DEEPAKNTR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.8%1-day move
₹1361.00
prior close
₹1369.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.4+0.2-0.8-5.8-0.4+1.0+2.2+1.8+4.6+27.8+23.8+26.4+15.0
Up moveDown movePending
AI summary

Deepak Nitrite Limited has informed the exchange that its wholly owned subsidiary, Deepak Chem Tech Limited (DCTL), has allotted 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at face value of ₹100 each. Deepak Phenolics Limited (another wholly owned subsidiary) was allotted ₹110 Crores worth of OCRPS (1.10 crore shares), while Deepak Nitrite Limited itself was allotted ₹25 Crores worth (25 lakh shares), aggregating to a total infusion of ₹135 Crores. DCTL operates plants for Fluorination, Nitric Acid, Nitration, and Hydrogenation in Gujarat and had a turnover of ₹9.43 Crores in FY25. The funds will be used to strengthen DCTL's capital base and support project and general corporate expenses. The transaction was done on an arms-length basis at par value, with cash routed through normal banking channels, and no regulatory approvals were required.

Likely market impact

This is an internal restructuring/capital infusion within the Deepak Nitrite group and does not change the parent's 100% control over DCTL. It signals continued investment in DCTL's chemical project pipeline, though near-term impact on listed entity shareholders is neutral as the subsidiary is currently loss-making at the revenue level (₹9.43 Cr FY25 turnover vs. significant capital base).